|Bid||6.98 x 1300|
|Ask||7.10 x 1300|
|Day's range||6.24 - 7.03|
|52-week range||3.28 - 20.75|
|Beta (5Y monthly)||0.42|
|PE ratio (TTM)||N/A|
|Earnings date||01 Aug 2022 - 05 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||10.80|
Enanta Pharmaceuticals (ENTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
The big shareholder groups in Esperion Therapeutics, Inc. ( NASDAQ:ESPR ) have power over the company. Insiders often...
Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.